Clinical trial
FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients…
NCT00486798 · AstraZeneca, Industry · Terminated
Key facts
| NCT number | NCT00486798 |
|---|---|
| Title | FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis |
| Acronym | FAST |
| Lead sponsor | AstraZeneca, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Psychotic Disorders, Schizophrenia, Bipolar Disorder |
| Intervention type | Drug, Procedure |
| Interventions | Quetiapine, Rating Scales, Self Assessment Form, Blood and urine samples, Sleeping pattern |
| Start date | May 1, 2007 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jun 15, 2007 |
| Last update posted | Dec 10, 2010 |
| Countries | Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: